Kiljander, Toni
Poussa, Tuija
Helin, Timo
Jaakkola, Antero
Venho, Kari
Lehtimäki, Lauri http://orcid.org/0000-0003-1586-4998
Funding for this research was provided by:
Boehringer Ingelheim
Article History
Received: 22 January 2020
Accepted: 27 March 2020
First Online: 15 April 2020
Ethics approval and consent to participate
: The study was approved by the Ethics Committee of Pirkanmaa Health Care District, and every patient gave written informed consent.
: Not applicable.
: Dr. Kiljander: No competing interests.Ms. Poussa: No competing interests.Dr. Helin: No competing interests.Dr. Jaakkola is a former employee of Boehringer-Ingelheim, Finland.Dr. Venho: personal fees and travel expenses from Boehringer Ingelheim and GSK.Dr. Lehtimäki: personal fees for consultations, lectures and advisory board memberships from AstraZeneca, Boehringer-Ingelheim, Chiesi, GSK, Munidpharma, Novartis, OrionPharma, Sanofi and Teva.